<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hemostatic aspects of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) present unique challenges to clinicians and laboratory personnel alike, particularly in the perioperative period </plain></SENT>
<SENT sid="1" pm="."><plain>These challenges are especially evident in patients requiring cardiac valve replacement surgery </plain></SENT>
<SENT sid="2" pm="."><plain>However, the literature outlining the optimal approach in such patients is limited </plain></SENT>
<SENT sid="3" pm="."><plain>We present the case of a 25-year-old woman with severe <z:hpo ids='HP_0001659'>aortic regurgitation</z:hpo> as a result of APS with particular reference to the precautions necessary during perioperative care </plain></SENT>
<SENT sid="4" pm="."><plain>Particularly important are the prevention of thrombotic or hemorrhagic complications, management of associated <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, and laboratory methods of perioperative anticoagulation monitoring in the setting of <z:hpo ids='HP_0005542'>prolonged clotting times</z:hpo> </plain></SENT>
</text></document>